Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain.

Rodriguez-Gaztelumendi A, Spahn V, Labuz D, Machelska H, Stein C.

Pain. 2018 Nov;159(11):2277-2284. doi: 10.1097/j.pain.0000000000001328.

2.

Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.

Spahn V, Del Vecchio G, Rodriguez-Gaztelumendi A, Temp J, Labuz D, Kloner M, Reidelbach M, Machelska H, Weber M, Stein C.

Sci Rep. 2018 Jun 12;8(1):8965. doi: 10.1038/s41598-018-27313-4.

3.

Polyglycerol-opioid conjugate produces analgesia devoid of side effects.

González-Rodríguez S, Quadir MA, Gupta S, Walker KA, Zhang X, Spahn V, Labuz D, Rodriguez-Gaztelumendi A, Schmelz M, Joseph J, Parr MK, Machelska H, Haag R, Stein C.

Elife. 2017 Jul 4;6. pii: e27081. doi: 10.7554/eLife.27081.

4.

A nontoxic pain killer designed by modeling of pathological receptor conformations.

Spahn V, Del Vecchio G, Labuz D, Rodriguez-Gaztelumendi A, Massaly N, Temp J, Durmaz V, Sabri P, Reidelbach M, Machelska H, Weber M, Stein C.

Science. 2017 Mar 3;355(6328):966-969. doi: 10.1126/science.aai8636. Erratum in: Science. 2017 Jun 9;356(6342):.

PMID:
28254944
5.

An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression.

Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A.

Exp Brain Res. 2014 Jun;232(6):1793-803. doi: 10.1007/s00221-014-3871-7. Epub 2014 Mar 1.

PMID:
24584836
6.

CB1 receptor autoradiographic characterization of the individual differences in approach and avoidance motivation.

Laricchiuta D, Rojo ML, Rodriguez-Gaztelumendi A, Ferlazzo F, Petrosini L, Fowler CJ.

PLoS One. 2012;7(7):e42111. doi: 10.1371/journal.pone.0042111. Epub 2012 Jul 27.

7.

Differential adaptive changes on serotonin and noradrenaline transporters in a rat model of peripheral neuropathic pain.

Rojo ML, Rodríguez-Gaztelumendi A, Pazos Á, Díaz Á.

Neurosci Lett. 2012 May 2;515(2):181-6. doi: 10.1016/j.neulet.2012.03.050. Epub 2012 Mar 28.

PMID:
22480692
8.

Lysophosphatidylinositol stimulates [³⁵S]GTPγS binding in the rat prefrontal cortex and hippocampus.

Rojo ML, Rodriguez-Gaztelumendi A, Fowler CJ.

Neurochem Res. 2012 May;37(5):1037-42. doi: 10.1007/s11064-012-0704-6. Epub 2012 Jan 22.

PMID:
22270908
9.

Comparison of the effects of nicotine upon the transcellular electrical resistance and sucrose permeability of human ECV304/rat C6 co-cultures and human CaCo₂ cells.

Rodriguez-Gaztelumendi A, Alvehus M, Andersson T, Jacobsson SO.

Toxicol Lett. 2011 Nov 10;207(1):1-6. doi: 10.1016/j.toxlet.2011.08.014. Epub 2011 Aug 26.

PMID:
21889975
10.

New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.

Vidal R, Pilar-Cuéllar F, dos Anjos S, Linge R, Treceño B, Vargas VI, Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizán EM, Pazos A.

Curr Pharm Des. 2011;17(5):521-33. Review.

PMID:
21375480
11.

Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?

Fowler CJ, Rojo ML, Rodriguez-Gaztelumendi A.

Exp Neurol. 2010 Jul;224(1):37-47. doi: 10.1016/j.expneurol.2010.03.021. Epub 2010 Mar 29. Review.

PMID:
20353772
12.

Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A.

J Neurochem. 2009 Mar;108(6):1423-33. doi: 10.1111/j.1471-4159.2009.05898.x. Epub 2009 Jan 22.

13.

WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.

Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A.

Neuropharmacology. 2008 Dec;55(8):1391-6. doi: 10.1016/j.neuropharm.2008.08.038. Epub 2008 Sep 17.

PMID:
18809415

Supplemental Content

Loading ...
Support Center